Companies that report earnings above market expectations typically see a positive short-term reaction in their stock price as investors adjust their valuations based on the new information. BioAtla's better-than-expected Q1 GAAP EPS results indicate strong financial performance, likely leading to increased investor confidence and demand for BCAB shares.